Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement | Zendy

Guy Witberg | Zendy; Tali Steinmetz | Zendy; Uri Landes | Zendy; Rotem Pistiner Hanit | Zendy; Hefziba Green | Zendy; Shira Goldman | Zendy; Hana VakninAssa | Zendy; Pablo Codner | Zendy; Leor Perl | Zendy; Benaya RozenZvi | Zendy; Ran Kornowski | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve Replacement

Author(s) -

Guy Witberg,

Tali Steinmetz,

Uri Landes,

Rotem Pistiner Hanit,

Hefziba Green,

Shira Goldman,

Hana VakninAssa,

Pablo Codner,

Leor Perl,

Benaya RozenZvi,

Ran Kornowski

Publication year - 2021

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2021.3296

Subject(s) - medicine , valve replacement , renal function , kidney disease , retrospective cohort study , valvular heart disease , cardiology , cohort , population , cohort study , surgery , stenosis , environmental health

Key Points Question Is transcatheter aortic valve replacement (TAVR) associated with changes in kidney function or midterm mortality? Findings In a cohort study of 894 patients who underwent TAVR, kidney function improved or remained stable in 80.6% (improved in 36.8%) of patients 1 month after TAVR. Steady state kidney function had a stronger association with mortality than did baseline kidney function. Meaning Results suggest that overall, TAVR is safe in terms of kidney outcomes and has the potential to improve kidney function and provide an additive benefit to its cardiac benefits.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research